US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 5.150
  • -0.230-4.28%
Close Mar 28 16:00 ET
  • 5.150
  • 0.0000.00%
Post 16:00 ET
23.55MMarket Cap-0.33P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-65.96%7.14M
-51.56%1.46M
-47.47%2.56M
-85.71%991K
-65.37%2.14M
-49.92%20.97M
-7.88%3M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
Operating revenue
-86.14%2.81M
--0
-73.33%1.3M
--0
-75.47%1.51M
-51.59%20.27M
-29.32%2.31M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
Cost of revenue
-89.96%620K
0
0
0
-76.06%620K
-15.03%6.17M
-71.46%608K
-49.00%1.56M
1.42M
24.46%2.59M
Gross profit
-55.95%6.52M
-39.27%1.46M
-22.73%2.56M
-82.03%991K
-57.62%1.52M
-57.24%14.79M
111.85%2.4M
-57.36%3.31M
-76.02%5.52M
31.97%3.58M
Operating expense
-56.46%59.34M
-80.00%7M
-75.67%7.84M
-58.48%15.72M
-7.83%28.78M
11.59%136.29M
7.91%35M
1.91%32.21M
37.78%37.86M
1.98%31.23M
Selling and administrative expenses
-4.56%26.39M
4.31%6.83M
-4.79%6.4M
-15.24%6.37M
-1.11%6.79M
-8.23%27.65M
2.39%6.55M
-2.27%6.72M
-0.32%7.51M
-26.33%6.86M
-General and administrative expense
-4.56%26.39M
4.31%6.83M
-4.79%6.4M
-15.24%6.37M
-1.11%6.79M
-8.23%27.65M
2.39%6.55M
-2.27%6.72M
-0.32%7.51M
-26.33%6.86M
Research and development costs
-69.77%32.81M
-99.40%171K
-94.65%1.36M
-69.29%9.31M
-9.74%21.96M
18.10%108.51M
9.25%28.42M
3.08%25.45M
52.27%30.31M
14.39%24.33M
Depreciation amortization depletion
9.23%142K
--0
135.48%73K
25.81%39K
3.45%30K
1.56%130K
21.88%39K
-3.13%31K
-3.13%31K
-9.38%29K
-Depreciation and amortization
9.23%142K
--0
135.48%73K
25.81%39K
3.45%30K
1.56%130K
21.88%39K
-3.13%31K
-3.13%31K
-9.38%29K
Operating profit
56.53%-52.82M
82.99%-5.55M
81.73%-5.28M
54.47%-14.73M
1.39%-27.27M
-38.80%-121.5M
-4.15%-32.61M
-21.19%-28.9M
-623.17%-32.34M
0.94%-27.65M
Net non-operating interest income expense
-1,302.81%-8.47M
-333.94%-2.62M
-1.96M
-1.91M
-1.98M
-604K
-604K
0
0
0
Non-operating interest expense
1,302.81%8.47M
333.94%2.62M
--1.96M
--1.91M
--1.98M
--604K
--604K
--0
--0
--0
Other net income (expense)
-378.14%-9.97M
-89.59%91K
-704.50%-5.24M
-492.68%-3.38M
-247.11%-1.45M
73.99%3.59M
-9.71%874K
30.23%866K
223.68%861K
508.02%985K
Special income (charges)
---12.8M
---330K
---6M
---4.07M
---2.4M
--0
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
--5.57M
---124K
--707K
--2.58M
--2.4M
--0
--0
--0
--0
--0
-Less:Impairment of capital assets
--4.27M
--0
--4.27M
----
----
--0
--0
--0
----
----
-Write off
--2.96M
--454K
--1.02M
--1.49M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
-21.14%2.83M
-51.83%421K
-11.55%766K
-19.98%689K
-3.35%952K
73.99%3.59M
-9.71%874K
30.23%866K
223.68%861K
508.02%985K
Income before tax
39.87%-71.27M
75.02%-8.08M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
Income tax
-398K
0
Net income
40.20%-70.87M
76.25%-7.68M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
Net income continuous Operations
40.20%-70.87M
76.25%-7.68M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
Minority interest income
Net income attributable to the parent company
40.20%-70.87M
76.25%-7.68M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.20%-70.87M
76.25%-7.68M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
Basic earnings per share
40.86%-15.53
75.56%-1.73
55.77%-2.76
36.21%-4.44
-14.29%-6.72
-37.34%-26.26
-5.36%-7.08
-20.93%-6.24
-625.00%-6.96
5.77%-5.88
Diluted earnings per share
40.86%-15.53
75.56%-1.73
55.77%-2.76
36.21%-4.44
-14.29%-6.72
-37.34%-26.26
-5.36%-7.08
-20.93%-6.24
-625.00%-6.96
5.77%-5.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -65.96%7.14M-51.56%1.46M-47.47%2.56M-85.71%991K-65.37%2.14M-49.92%20.97M-7.88%3M-55.00%4.87M-69.86%6.93M28.71%6.17M
Operating revenue -86.14%2.81M--0-73.33%1.3M--0-75.47%1.51M-51.59%20.27M-29.32%2.31M-55.00%4.87M-69.86%6.93M28.71%6.17M
Cost of revenue -89.96%620K000-76.06%620K-15.03%6.17M-71.46%608K-49.00%1.56M1.42M24.46%2.59M
Gross profit -55.95%6.52M-39.27%1.46M-22.73%2.56M-82.03%991K-57.62%1.52M-57.24%14.79M111.85%2.4M-57.36%3.31M-76.02%5.52M31.97%3.58M
Operating expense -56.46%59.34M-80.00%7M-75.67%7.84M-58.48%15.72M-7.83%28.78M11.59%136.29M7.91%35M1.91%32.21M37.78%37.86M1.98%31.23M
Selling and administrative expenses -4.56%26.39M4.31%6.83M-4.79%6.4M-15.24%6.37M-1.11%6.79M-8.23%27.65M2.39%6.55M-2.27%6.72M-0.32%7.51M-26.33%6.86M
-General and administrative expense -4.56%26.39M4.31%6.83M-4.79%6.4M-15.24%6.37M-1.11%6.79M-8.23%27.65M2.39%6.55M-2.27%6.72M-0.32%7.51M-26.33%6.86M
Research and development costs -69.77%32.81M-99.40%171K-94.65%1.36M-69.29%9.31M-9.74%21.96M18.10%108.51M9.25%28.42M3.08%25.45M52.27%30.31M14.39%24.33M
Depreciation amortization depletion 9.23%142K--0135.48%73K25.81%39K3.45%30K1.56%130K21.88%39K-3.13%31K-3.13%31K-9.38%29K
-Depreciation and amortization 9.23%142K--0135.48%73K25.81%39K3.45%30K1.56%130K21.88%39K-3.13%31K-3.13%31K-9.38%29K
Operating profit 56.53%-52.82M82.99%-5.55M81.73%-5.28M54.47%-14.73M1.39%-27.27M-38.80%-121.5M-4.15%-32.61M-21.19%-28.9M-623.17%-32.34M0.94%-27.65M
Net non-operating interest income expense -1,302.81%-8.47M-333.94%-2.62M-1.96M-1.91M-1.98M-604K-604K000
Non-operating interest expense 1,302.81%8.47M333.94%2.62M--1.96M--1.91M--1.98M--604K--604K--0--0--0
Other net income (expense) -378.14%-9.97M-89.59%91K-704.50%-5.24M-492.68%-3.38M-247.11%-1.45M73.99%3.59M-9.71%874K30.23%866K223.68%861K508.02%985K
Special income (charges) ---12.8M---330K---6M---4.07M---2.4M--0--0--0--0--0
-Less：Restructuring and merger&acquisition --5.57M---124K--707K--2.58M--2.4M--0--0--0--0--0
-Less:Impairment of capital assets --4.27M--0--4.27M----------0--0--0--------
-Write off --2.96M--454K--1.02M--1.49M------0--0--0--0----
Other non- operating income (expenses) -21.14%2.83M-51.83%421K-11.55%766K-19.98%689K-3.35%952K73.99%3.59M-9.71%874K30.23%866K223.68%861K508.02%985K
Income before tax 39.87%-71.27M75.02%-8.08M55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M
Income tax -398K0
Net income 40.20%-70.87M76.25%-7.68M55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M
Net income continuous Operations 40.20%-70.87M76.25%-7.68M55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M
Minority interest income
Net income attributable to the parent company 40.20%-70.87M76.25%-7.68M55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.20%-70.87M76.25%-7.68M55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M
Basic earnings per share 40.86%-15.5375.56%-1.7355.77%-2.7636.21%-4.44-14.29%-6.72-37.34%-26.26-5.36%-7.08-20.93%-6.24-625.00%-6.965.77%-5.88
Diluted earnings per share 40.86%-15.5375.56%-1.7355.77%-2.7636.21%-4.44-14.29%-6.72-37.34%-26.26-5.36%-7.08-20.93%-6.24-625.00%-6.965.77%-5.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
-0.88%
NVIDIA
NVDA
-1.58%
Broadcom
AVGO
-1.67%
Taiwan Semiconductor
TSM
-1.78%
ASML Holding
ASML
-2.32%

Unlock the Full List